A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

Clinical trial NCT03348618 · UNKNOWN

Trial details

NCT number: NCT03348618
Sponsor: IMMUNOe Research Centers
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Pediatric Acute-Onset Neuropsychiatric Syndrome Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections

Start date: 2017-11-24
Primary completion: 2019-11-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.